• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供体肝活检的作用:5449 例肝移植受者的分析。

The role of deceased donor liver biopsy: An analysis of 5449 liver transplant recipients.

机构信息

Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Clin Transplant. 2020 May;34(5):e13835. doi: 10.1111/ctr.13835. Epub 2020 Mar 23.

DOI:10.1111/ctr.13835
PMID:32068301
Abstract

BACKGROUND

No standard exists for the use of deceased donor liver biopsy during procurement. We sought to evaluate liver biopsy and the impact of findings on outcomes and graft utilization.

METHODS

A prospective observational study of donors after neurologic determination of death was conducted from 02/2012-08/2017 (16 OPOs). Donor data were collected through the UNOS Donor Management Goals Registry Web Portal and linked to the Scientific Registry of Transplant Recipients (SRTR) for recipient outcomes. Recipients of biopsied donor livers (BxDL) were studied and a Cox proportional hazard analysis was used to identify independent predictors of 1-year graft survival.

RESULTS

Data from 5449 liver transplant recipients were analyzed, of which 1791(33%) received a BxDL. There was no difference in graft or patient survival between the non-BxDL and BxDL recipient groups. On adjusted analysis of BxDL recipients, macrosteatosis (21%-30%[n = 148] and >30%[n = 92]) was not found to predict 1-year graft survival, whereas increasing donor age (HR1.02), donor Hispanic ethnicity (HR1.62), donor INR (HR1.18), and recipient life support (HR2.29) were.

CONCLUSIONS

Excellent graft and patient survival can be achieved in recipients of BxDL grafts. Notably, as demonstrated by the lack of effect of macrosteatosis on survival, donor to recipient matching may contribute to these outcomes.

摘要

背景

在获取供体肝脏时,没有使用已故供体肝脏活检的标准。我们旨在评估肝脏活检及其对结局和移植物利用的影响。

方法

从 2012 年 2 月至 2017 年 8 月(16 个 OPO)进行了一项对脑死亡供体的前瞻性观察性研究。通过 UNOS 供体管理目标登记册网络门户收集供体数据,并与 Scientific Registry of Transplant Recipients(SRTR)联系以获取受者结局。研究了接受活检供体肝脏(BxDL)的受者,并使用 Cox 比例风险分析确定了 1 年移植物存活率的独立预测因子。

结果

对 5449 例肝移植受者的数据进行了分析,其中 1791 例(33%)接受了 BxDL。非 BxDL 和 BxDL 受者组之间的移植物或患者存活率无差异。在对 BxDL 受者的调整分析中,未发现宏观脂肪变性(21%-30%[n=148]和>30%[n=92])预测 1 年移植物存活率,而供体年龄增加(HR1.02)、供体西班牙裔(HR1.62)、供体 INR(HR1.18)和受者生命支持(HR2.29)是。

结论

BxDL 移植物受者可获得出色的移植物和患者存活率。值得注意的是,正如宏观脂肪变性对生存无影响所表明的那样,供体与受者匹配可能有助于实现这些结局。

相似文献

1
The role of deceased donor liver biopsy: An analysis of 5449 liver transplant recipients.供体肝活检的作用:5449 例肝移植受者的分析。
Clin Transplant. 2020 May;34(5):e13835. doi: 10.1111/ctr.13835. Epub 2020 Mar 23.
2
Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.美国的肝移植:器官共享联合网络肝脏移植登记处的一份报告。
Clin Transpl. 1999:23-34.
3
UNOS Liver Registry: ten year survivals.器官共享联合网络肝脏登记处:十年生存率
Clin Transpl. 2006:29-39.
4
Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.美国的肝脏移植:器官获取与移植网络的一份报告。
Clin Transpl. 2000:19-30.
5
The OPTN/UNOS Renal Transplant Registry.器官获取与移植网络/美国器官共享联合网络肾脏移植登记处
Clin Transpl. 2005:1-16.
6
The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.活检供体肝:将宏观脂肪变性纳入高危供体评估。
Liver Transpl. 2010 Jul;16(7):874-84. doi: 10.1002/lt.22085.
7
A contemporary analysis of 20,086 deceased donor liver biopsies.20,086 例已故供体肝活检的当代分析。
World J Surg. 2024 Feb;48(2):437-445. doi: 10.1002/wjs.12034. Epub 2023 Dec 15.
8
Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.供肝大泡性脂肪变对供体利用率和移植后结局的影响。
Transplantation. 2023 Feb 1;107(2):405-409. doi: 10.1097/TP.0000000000004291. Epub 2022 Aug 31.
9
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.在 HCV 阳性供者肝移植到 HCV 阴性受者中增加利用率和优异的初始结果:HCV 阳性供者肝移植后的结果。
Hepatology. 2019 Jun;69(6):2381-2395. doi: 10.1002/hep.30540. Epub 2019 Apr 11.
10
The outcome of liver grafts procured from hepatitis C-positive donors.来自丙型肝炎阳性供体的肝移植结果。
Transplantation. 2002 Feb 27;73(4):582-7. doi: 10.1097/00007890-200202270-00018.

引用本文的文献

1
Development of a portable device to quantify hepatic steatosis in potential donor livers.开发一种用于量化潜在供体肝脏肝脂肪变性的便携式设备。
Front Transplant. 2023 Jun 23;2:1206085. doi: 10.3389/frtra.2023.1206085. eCollection 2023.
2
Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.口服 N-乙酰半胱氨酸可减少 IFN-γ 的产生并改善脂肪肝的缺血再灌注损伤。
Front Immunol. 2022 Sep 5;13:898799. doi: 10.3389/fimmu.2022.898799. eCollection 2022.